Is Brightspring Health Services Inc (BTSG) a risky stock?
As of July 21, 2026, Clavix grades Brightspring Health Services Inc (BTSG) B+ for risk, a composite score of 79 out of 100 on an A+ to F scale, which puts BTSG in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind BTSG's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how BTSG scores on each, as of July 21, 2026.
What's moving BTSG's risk right now
Company-specific signals Clavix flags behind BTSG's current grade, drawn from recent news and filings as of July 21, 2026.
The consistent quarterly payout signals management's confidence in cash flow stability, though the modest 1.4% yield suggests the dividend is not a primary value driver for invest…
Earnings beats or upward guidance revisions are reducing near-term uncertainty and supporting multiple expansion.
Declining volatility suggests the market is becoming more confident in the near-term outlook.
What a B+ grade means
On the Clavix A+ to F scale, BTSG's composite of 79 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell BTSG or any security. Grades are risk indicators, not predictions of return. Data may be delayed.